×
0.0264550264550265 0.201058201058201 0.137566137566137 0.156931216931217 0.0952380952380953 0.0264550264550265 0.035026455026455 0.0352910052910053
Stockreport

Catabasis Pharma's edasalonexent shows positive effect in mid-stage DMD study; shares up 62% [Seeking Alpha]

CATABASIS PHARMACEUTICALS (CATB)  More Company Research Source: Seeking Alpha
Last catabasis pharmaceuticals earnings: 5/10 08:05 am Check Earnings Report
US:NASDAQ Investor Relations: ir.catabasis.com/investor-overview
PDF Catabasis Pharma's edasalonexent shows positive effect in mid-stage DMD study; shares up 62%Thinly traded nano cap Catabasis Pharmaceuticals (CATB+61.6%) is up on a whopping 34x surge in volume in response to itsannouncement of positive results from the extension portion of a Phase 2 clinical trial, MoveDMD, assessing edasalonexent in boys with Duchenne muscular dystrophy (DMD).Consistent improvements in all assessments of muscle function were observed after more than a year of treatment compared to the rate of change in the pre-specified control period. Significant longer-term reductions in muscle enzymes and C-reactive protein were also noted.The data will be presented on Saturday, February 17, at the XVI International Conference on Duchenne and Becker Muscular Dystrophy in Rome.Selected DMD-related tickers: (SRPT-0.6%)(SMMT+2.6%)(CAPR+2.8%)(SLDB+0.2%)Previously:Catabasis Pharma's edasalonexent shows long-term treatment effect in mid-stage DMD study; shares ahead 59% premarket (Oct. [Read more]

IMPACT SNAPSHOT EVENT TIME: CATB
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CATB alerts
from News Quantified